Skip to main content
Targeting the host rather than the virus could kill the common cold

A drug that blocks a key protein in the body's cells that rhinoviruses use to self-replicate could cure the common cold, according to a study published in Nature Chemistry, and human clinical trials on the compound could get underway within two years. The compound worked quickly in lab experiments on human lung cells, the researchers reported.

Full Story: